S.S. Pharma Traders Private Limited - Due diligence report

A 360° intelligence report on S.S. Pharma Traders Private Limited: trust score, financial health, credit view, compliance, directors, growth…

2022-07-25 Gorakhpur, Uttar Pradesh Active Unlisted
Share
Connect MCP
SP S.S. Pharma Traders Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

S.S. Pharma Traders Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
82/100
Trust Score
Low Risk

S.S. Pharma Traders Private Limited is assessed as Low Risk with a Trust Score of 82/100. S.S. Pharma Traders Private Limited is an active private limited indian non-government company incorporated in 2022, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 07 Aug 2026 from the latest processed filings. S.S. Pharma Traders Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
30/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 30/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 1 open (14.00 cr) · 2 satisfied (52.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Hdfc Bank Limited1 48.0 cr
Tata Capital Financial Services Limited1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 2 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
SHAHBAZ AHMAD SIDDIQUI 01234567 Director 01/04/2018 6 yrs Approved
SAMBIT MOHANTY 01234567 Director 01/04/2018 6 yrs Approved
Satyendra Tiwari 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Entero Healthcare Solutions Limited
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Entero Healthcare Solutions Limited Holding Company 74.00%

Key managerial personnel: SHAHBAZ AHMAD SIDDIQUI (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Young company (4 years).
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence92/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment56/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 14.00 cr already registered.
  • Compliance record supports lending.
Investor view42/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
07 Oct 2025
Director appointed
Satyendra Tiwari (Additional Director)
17 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
27 Mar 2025
Charge satisfied
Tata Capital Financial Services Limited
06 Nov 2024
Charge created
Hdfc Bank Limited - 14.00 cr
29 Mar 2024
Director ceased
SHAHBAZ AHMAD SIDDIQUI
03 Aug 2023
Director ceased
SAMBIT MOHANTY
Director ceased
PRASHANT PALEJA
19 Jul 2023
Charge created
Tata Capital Financial Services Limited - 7.00 cr
28 Apr 2023
Charge satisfied
Others
02 Mar 2023
Director appointed
SAMBIT MOHANTY (Director)
Director ceased
SAIMA SIDDIQUI
24 Nov 2022
Charge created
Others - 45.00 cr
25 Jul 2022
Incorporated
Registered with Roc Kanpur
Director appointed
SHAHBAZ AHMAD SIDDIQUI (Whole-time director)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Dheeshithan Agencies Export House Private Limited U15200TN2021PTC145092 Poonamallee, Tamil Nadu, India
Chemex Organochem Private Limited U24296MH2008PTC181673 Mumbai, Maharashtra, India
Sharaya Cosmocare Private Limited U24246DL2013PTC252642 Delhi, Delhi, India
Drillman Equipment India Private Limited U28221PN2021FTC203418 Pune, Maharashtra, India
Bhavi International Private Limited U51900MH1994PTC082456 Mumbai, Maharashtra, India
Shree Jaysurya Steels Private Limited U51420TN2006PTC059341 Chennai, Tamil Nadu, India
Hamy Steel Private Limited U27106MH1990PTC056140 Pune, Maharashtra, India
Shree Balaji Auto Distributors Private Limited U34102WB2008PTC125075 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify S.S. Pharma Traders Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of S.S. Pharma Traders Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 30/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for S.S. Pharma Traders Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether S.S. Pharma Traders Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for S.S. Pharma Traders Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is S.S. Pharma Traders Private Limited an active company?

S.S. Pharma Traders Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is S.S. Pharma Traders Private Limited financially healthy?

S.S. Pharma Traders Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with S.S. Pharma Traders Private Limited?

Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls S.S. Pharma Traders Private Limited?

The ultimate holding entity is Entero Healthcare Solutions Limited. 3 active director(s) are on record.

Does S.S. Pharma Traders Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is S.S. Pharma Traders Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to S.S. Pharma Traders Private Limited?

Its Credit Risk Score is 30/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.